The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
The Association of Aminoglycoside Plasma Levels with Mortality in Patients with Gram-Negative Bacteremia
Abstract
To determine the association of aminoglycoside levels with mortality from gram-negative bacteremia, we analyzed the case reports of patients from four prospective, randomized, and controlled clinical trials of gentamicin, tobramycin, and amikacin. Twelve (13.5%) of 89 patients died. One (2.4%) death occurred in 41 patients with early (1-hr postinfusion) peak concentrations of greater than 5 micrograms/ml of gentamicin and tobramycin and of greater than 20 micrograms of amikacin/ml; nine deaths (20.9%) occurred in 43 patients with lower concentrations. Five (8.3%) deaths occurred in 60 patients with mean peak concentrations for the entire course of therapy of greater than 5 micrograms/ml of gentamicin and tobramycin and of greater than 20 micrograms of amikacin/ml; five (20.8%) deaths occurred in 24 patients with lower concentrations. Stepwise discriminant analysis showed that therapeutic early peak concentration was a significant factor in the presence of three other factors: severity of underlying illness, peak temperature, and initial leukocyte count. The results suggest the importance of achieving adequate early aminoglycoside levels in patients with gram-negative bacteremia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
- STATISTICAL PACKAGE FOR SOCIAL SCIENCES
(2014) · Statistical Methods in Psychiatry Research and SPSS · doi:10.1201/b17560-26 · Cited by 12,056
SPSS: statistical package for the social sciences
Nie, N. H. (1975) · Infoscience (Ecole Polytechnique Fédérale de Lausanne) · Cited by 3,461
Kreger, B. E., Craven, D. E., Carling, P. C., & McCabe, W. R. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90101-1 · Cited by 595
McGowan, J. E., Barnes, M. W., & Finland, M. (1975) · Journal of Infectious Diseases · doi:10.1093/infdis/132.3.316 · Cited by 498
DuPONT, H. L., & SPINK, W. W. (1969) · Medicine · doi:10.1097/00005792-196907000-00003 · Cited by 418
Gram-Negative Bacteremia: II. Clinical, Laboratory, and Therapeutic Observations
McCABE, W. R. (1962) · Archives of Internal Medicine · doi:10.1001/archinte.1962.03620240038007 · Cited by 384
Experience in Monitoring Gentamicin Therapy during Treatment of Serious Gram-Negative Sepsis
Noone, P., Parsons, T. M. C., Pattison, J. R., Slack, R. C. B., Garfield-Davies, D., & Hughes, K. (1974) · BMJ · doi:10.1136/bmj.1.5906.477 · Cited by 347
Factors Affecting Mortality of Gram-Negative Rod Bacteremia
Bryant, R. E. (1971) · Archives of Internal Medicine · doi:10.1001/archinte.127.1.120 · Cited by 298
Controlled Comparison of Amikacin and Gentamicin
Smith, C. R., Baughman, K. L., Edwards, C. Q., et al. (1977) · New England Journal of Medicine · doi:10.1056/nejm197702172960701 · Cited by 259
Self-citationThe Importance of Underlying Disease in Patients With Gram-Negative Bacteremia
Freid, M. A. (1968) · Archives of Internal Medicine · doi:10.1001/archinte.121.5.418 · Cited by 228
Recent Experience with Bacillemia Due to Gram-Negative Organisms
Myerowitz, R. L., Medeiros, A. A., & O’Brien, T. (1971) · The Journal of Infectious Diseases · doi:10.1093/infdis/124.3.239 · Cited by 161
Simultaneous antibiotic levels in “breakthrough” gram-negative rod bacteremia
Anderson, E. T., Young, L. S., & Hewitt, W. L. (1976) · The American Journal of Medicine · doi:10.1016/0002-9343(76)90328-4 · Cited by 135
Cited by
Moore, R. D., Lietman, P. S., & Smith, C. R. (1987) · Journal of Infectious Diseases · doi:10.1093/infdis/155.1.93 · Cited by 1,139
Self-citationCystic Fibrosis Pulmonary Guidelines: Treatment of Pulmonary Exacerbations
Flume, P. A., Mogayzel, P. J., Robinson, K. A., Goss, C. H., Rosenblatt, R. L., Kuhn, R. J., Marshall, B. C., & and the Clinical Practice Guidelines for Pulmonary Therapies Committee (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200812-1845pp · Cited by 738
Correlation of Antimicrobial Pharmacokinetic Parameters with Therapeutic Efficacy in an Animal Model
Vogelman, B., Gudmundsson, S., Leggett, J., Turnidge, J., Ebert, S., & Craig, W. A. (1988) · The Journal of Infectious Diseases · doi:10.1093/infdis/158.4.831 · Cited by 720
Ventilator-Associated Pneumonia: Diagnosis, Treatment, and Prevention
Koenig, S. M., & Truwit, J. D. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00051-05 · Cited by 539
Single or multiple daily doses of aminoglycosides: a meta-analysis
Barza, M., Ioannidis, J. P., Cappelleri, J. C., & Lau, J. (1996) · BMJ · doi:10.1136/bmj.312.7027.338 · Cited by 450
Metadata
- Authors
- Moore, R. D., Smith, C. R., & Lietman, P. S.
- Venue
- Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1984-03-01
- Volume
- 149
- Issue
- 3
- Pages
- 443-448
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W1998614168
- Cited by
- 390
- References
- 12
- FWCI
- 13.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.